Photo: Ida Marie Odgaard/Ritzau Scanpix/Sipa USA/Sipa via AP Images
May 31, 2023 02:42 PM EDT
Pharma
FDA+
Manufacturing

FDA warns about com­pound­ed semaglu­tide-based drugs

Tyler Patchen

News Reporter

The FDA has warned the pub­lic that com­pound­ed ver­sions of pop­u­lar GLP-1 drugs Ozem­pic and We­govy may not in­clude the same in­gre­di­ents as the pre­scrip­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times